Our guarantees are helping to save and protect peoples’ lives in more than 90 countries by making life-saving products more accessible. Guarantees accelerate access to innovative, effective products while securing long-term positive change in healthcare markets.
To date (June 2022), we have executed seven guarantees, bringing healthcare products to hundreds of thousands of people.
We screen all potential guarantees for development impact using our Development Impact framework. Read more below about the impact of our guarantees and the partnerships they support.
We partner with Hologic, Inc. and Clinton Health Access Initiative, Inc. (CHAI) to increase access to viral load testing for HIV and viral hepatitis. To date:
We partner with BASF and the Bill & Melinda Gates Foundation to accelerate access to Interceptor® G2 mosquito nets. To date:
We partner with UNICEF to increase access to essential COVID-19 and non-COVID-19 supplies. To date:
UNICEF's COVID-19 supplies
We partner with CHAI, Unitaid and Macleods Pharmaceutical Limited to increase access to 3HP preventive treatment for latent TB. We project that:
We partner with SD Biosensor and CHAI to increase access to dual rapid diagnostic tests for HIV and syphilis. Our projected impact (for guaranteed volumes):
We partnered with Gavi, the Vaccine Alliance and GSK to increase access to the RTS,S malaria vaccine. Our support for continued production of the RTS,S bulk antigen in advance of key policy and funding decisions with enable more millions children to be vaccinated.
RTS,S malaria vaccineWe partner with Gavi and the Open Society Foundations to enable countries to access additional COVID-19 vaccines through the COVAX Facility. The guarantee supports COVAX’s cost-sharing mechanism, which enables countries receiving vaccines through the COVAX Advance Market Commitment to procure additional doses using funds from multilateral development banks.
COVID-19 vaccines through COVAX